Hanmi Pharm Co Ltd
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 128940-KS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2010) — listing | $79,667 3.4× | $118,317 3.4× |
| Year 6 (2015) | $27,340 1.6× | $40,757 1.6× |
| Year 11 (2020) | $15,888 1.7× | $23,721 1.7× |
| Year 16 (2025) | $2,959 1.5× | $4,471 1.5× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 128940
For illustration only — not investment advice. Past performance is not indicative of future results.